Relative risk of pneumonitis or interstitial lung disease (ILD) associated with the use of cyclin-dependent kinase inhibitors (CDK4/6i): A systematic review and meta-analysis of phase 3 randomized controlled trials
Jahan, Nusrat, Wongsaengsak, Sariya, Rehman, Shabnam, Vinan-Vega, Myrian, Tijani, Lukman Aderoju, Hardwicke, Fred L.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Relative risk of HTN and major cardiovascular events associated with use of androgen receptor antagonists for nonmetastatic, castration-resistant prostate cancer
Jahan, Nusrat, Mogollon-Duffo, Francis, Rehman, Shabnam, Singal, Sakshi, Hardwicke, Fred L.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Relative risk of pneumonitis associated with first-line use of immune checkpoint inhibitors in advanced renal cell carcinoma
Jahan, Nusrat, Mogollon-Duffo, Francis, Meda, Srikala, Hardwicke, Fred L., Tijani, Lukman Aderoju
Published in Journal of clinical oncology (20.02.2020)
Published in Journal of clinical oncology (20.02.2020)
Get full text
Journal Article
A systematic review and meta- analysis of randomized controlled trials to evaluate the risk of pulmonary toxicities in patients with advanced breast cancer treated with everolimus
Swarup, Sriman, Thein, Kyaw Zin, Sultan, Anita, Yendala, Rachana, Hardwicke, Fred L., Jones, Catherine, Awasthi, Sanjay
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Risk of gastrointestinal and hepatic toxicities in patients with cancer treated with regorafenib: A systematic review and meta- analysis of randomized controlled trials
Yendala, Rachana, Thein, Kyaw Zin, Sultan, Anita, Swarup, Sriman, Tijani, Lukman, Hardwicke, Fred L., Jones, Catherine
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Risk of hematological toxicities in patients with advanced breast cancer treated with everolimus: A meta-analysis of phase 3 randomized controlled trials
Sultan, Anita, Thein, Kyaw Zin, Swarup, Sriman, D’Cunha, Ruth, Hardwicke, Fred L., Jones, Catherine, Awasthi, Sanjay
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Risk of gastrointestinal and hepatic toxicities in patients with advanced breast cancer treated with everolimus: A meta- analysis of phase 3 randomized controlled trials
Swarup, Sriman, Thein, Kyaw Zin, Sultan, Anita, Khan, Saad, Jones, Catherine, Hardwicke, Fred L., Awasthi, Sanjay
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Risk of secondary hematologic malignancies in patients with ovarian cancer treated with PARP inhibitors: A combined meta-analysis of seven phase III randomized controlled trials
Htut, Thura, Ball, Somedeb, Swarup, Sriman, Sultan, Anita, Han, Myat M., Myat, Yin Mon, Hardwicke, Fred L., Tijani, Lukman Aderoju, Thein, Kyaw
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Risk of gastrointestinal and hepatic toxicities in patients with metastatic solid tumors treated with cabozantinib: A systematic review and meta-analysis of randomized controlled trials
Zaw, Myo, Thein, Kyaw Zin, Han, Myat M., Igid, Henry Palangdao, Hardwicke, Fred L., Tijani, Lukman
Published in Journal of clinical oncology (01.11.2017)
Published in Journal of clinical oncology (01.11.2017)
Get full text
Journal Article
Screening for antineoplastic ionic liquids by targeting RLIP76
Khan, Muhammad Saad, Hardwicke, Fred L., Igid, Henry Palangdao, Kaleem, Hassan, Awasthi, Sanjay, Armstrong, Daniel
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Risk of hematological and gastrointestinal toxicities in patients with advanced neuroendocrine tumors treated with everolimus: A meta-analysis of phase 3 randomized controlled trials
Sultan, Anita, Thein, Kyaw Zin, Swarup, Sriman, Ball, Somedeb, Tijani, Lukman Aderoju, Awasthi, Sanjay, Jones, Catherine, Hardwicke, Fred L.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Risk of health-related quality of life events and pulmonary toxicities in patients with advanced neuroendocrine tumors treated with everolimus: A meta-analysis of phase 3 randomized controlled trials
Thein, Kyaw Zin, Sultan, Anita, Swarup, Sriman, Quirch, Miguel, Tijani, Lukman Aderoju, Hardwicke, Fred L., Jones, Catherine, Awasthi, Sanjay
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of hypophosphatemia, hypertension, and hematological toxicities in patients with cancer treated with regorafenib
Igid, Henry Palangdao, Thein, Kyaw Zin, Sultan, Anita, Swarup, Sriman, Awasthi, Sanjay, Jones, Catherine, Hardwicke, Fred L.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of health-related quality of life and metabolic events in patients with advanced breast cancer treated with everolimus
Ball, Somedeb, Thein, Kyaw Zin, Khan, Muhammad Saad, Swarup, Sriman, Sultan, Anita, Hardwicke, Fred L., D'Cunha, Nicholas C., Jones, Catherine
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Incidence of dermatological toxicities and fatigue in patients with cancer treated with regorafenib: A systematic review and meta- analysis of randomized controlled trials
Quirch, Miguel, Thein, Kyaw Zin, Khan, Muhammad Saad, Sultan, Anita, Swarup, Sriman, Tijani, Lukman Aderoju, Hardwicke, Fred L., Jones, Catherine
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Incidence of pneumonitis in patients with solid tumors treated with everolimus: A systematic review and meta- analysis of randomized controlled trials
Thein, Kyaw Zin, Sultan, Anita, Swarup, Sriman, Hardwicke, Fred L., Jones, Catherine, Tijani, Lukman Aderoju, Awasthi, Sanjay, D'Cunha, Nicholas C.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Risk of hematological, gastrointestinal, and hepatic toxicities in patients with advanced renal cell carcinoma treated with everolimus: A meta-analysis of phase 3 randomized controlled trials
Igid, Henry Palangdao, Thein, Kyaw Zin, Swarup, Sriman, Sultan, Anita, Hardwicke, Fred L., D'Cunha, Nicholas C., Tijani, Lukman Aderoju
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of fatigue and pain among patients with metastatic solid tumors treated with cabozantinib
Han, Myat M., Thein, Kyaw Zin, Zaw, Myo, D'Cunha, Luke, Perisetti, Abhilash, Hardwicke, Fred L., Tijani, Lukman
Published in Journal of clinical oncology (01.11.2017)
Published in Journal of clinical oncology (01.11.2017)
Get full text
Journal Article